New insights in the pathogenesis and therapy of idiopathic recurrent pericarditis in children

Clin Exp Rheumatol. 2013 Sep-Oct;31(5):788-94. Epub 2013 Aug 2.

Abstract

Pericarditis has several different causes, however, in about 70% of paediatric patients, a specific aetiology cannot be detected and the pericarditis is considered idiopathic. Recurrences may occur in up to 15-30% of cases. The pathogenesis of recurrent disease is controversial. Infectious, autoimmune and autoinflammatory pathways have been proposed as mechanisms involved in recurrences. Therapeutic strategies are not standardised, non-steroidal anti-inflammatory drugs at high dosages being the mainstay of therapy with the possible addition of low dose colchicine to prevent recurrences. Biological agents are considered a possible new therapeutic frontiers in the care of idiopathic recurrent pericarditis.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Age Factors
  • Anti-Inflammatory Agents / therapeutic use*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Biological Products / therapeutic use
  • Child
  • Child, Preschool
  • Colchicine / therapeutic use
  • Female
  • Humans
  • Male
  • Pericarditis / drug therapy*
  • Pericarditis / etiology
  • Pericarditis / immunology
  • Recurrence
  • Risk Factors
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Biological Products
  • Colchicine